|
This program provides brand name medications at no or low cost.
|
| Pharmaceutical Company |
United Therapeutics Corporation |
| Program Name |
United Therapeutics Bridge Patient Assistance program for Remodulin and Tyvaso |
| Program Address |
|
| Phone Number |
1-877-242-2738, 1-866-474-8326
|
| Fax Number |
|
| Medications on Program |
Remodulin Injection (treprostinil sodium)
|
| Application Forms |
Not Applicable |
On-line Application
|
No on-line application available at this time |
| Web Site |
No link available. |
| Eligibility Guidelines and Notes |
Those with federal health care or Massachusetts state coverage are not eligible.
Patient must have less than $25,000 in monthly household income AND meet one or more of the following: 1)has changed jobs or stopped working and has COBRA or HIPAA coverage 2) has insurance, but has exclusion period.
The medication must be used for a FDA-approved diagnosis. Patient must reside in the US, be under the direct care of a licensed US physician and receive health care services via the US health care system. Another number for the program is 866-344-4874. Patient will be excluded from this program if they lose insurance coverage by accepting PAP product. Patient financial, medication and insurance information is collected and reevaluated quarterly.
|
| Application Process |
The doctor or patient can call to request an application.
|
| Application Requirements |
The doctor must fill out a section and sign the application. The patient must also complete, sign the application and attach proof of income.
|
| Program Details |
The medication is sent to either the doctor's office or the patient's home. Patient are eligible for a maximum of six months or until they are able to obtain third party insurance, whichever comes first.
|
| Last Updated |
August 17, 2010 |